{"id":11696,"date":"2014-10-28T12:21:35","date_gmt":"2014-10-28T12:21:35","guid":{"rendered":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/"},"modified":"2014-10-28T12:21:35","modified_gmt":"2014-10-28T12:21:35","slug":"new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis","status":"publish","type":"rss_externo","link":"https:\/\/www.clpu.es\/en\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/","title":{"rendered":"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis"},"content":{"rendered":"<p>Positive new clinical data have been released on a drug candidate for ulcerative colitis. In the study, 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the treatment paradigm for ulcerative colitis patients. The latest results show that, after eight weeks of treatment with a 1 mg dose of RPC1063, 16.4 percent of patents were in clinical remission, as compared to 6.2 percent of patients on placebo.<br \/><a href='http:\/\/feeds.sciencedaily.com\/~r\/sciencedaily\/~3\/bCfgs57IlX8\/141028082135.htm' title='New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis' target='_blank' rel=\"noopener\">http:\/\/feeds.sciencedaily.com\/~r\/sciencedaily\/~3\/bCfgs57IlX8\/141028082135.htm<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"class_list":["post-11696","rss_externo","type-rss_externo","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - CLPU<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - CLPU\" \/>\n<meta property=\"og:description\" content=\"Positive new clinical data have been released on a drug candidate for ulcerative colitis. In the study, 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the treatment paradigm for ulcerative colitis patients. The latest results show that, after eight weeks of treatment with a 1 mg&hellip; Continue reading New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/\" \/>\n<meta property=\"og:site_name\" content=\"CLPU\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\\\/\",\"url\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\\\/\",\"name\":\"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - CLPU\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.clpu.es\\\/#website\"},\"datePublished\":\"2014-10-28T12:21:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.clpu.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RSS externos\",\"item\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.clpu.es\\\/#website\",\"url\":\"https:\\\/\\\/www.clpu.es\\\/\",\"name\":\"CLPU\",\"description\":\"Centro de L\u00e1seres Pulsados\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.clpu.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - CLPU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/","og_locale":"en_US","og_type":"article","og_title":"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - CLPU","og_description":"Positive new clinical data have been released on a drug candidate for ulcerative colitis. In the study, 199 patients with active, moderate to severe disease, the drug candidate RPC1063 has potential to significantly improve the treatment paradigm for ulcerative colitis patients. The latest results show that, after eight weeks of treatment with a 1 mg&hellip; Continue reading New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis","og_url":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/","og_site_name":"CLPU","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/","url":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/","name":"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis - CLPU","isPartOf":{"@id":"https:\/\/www.clpu.es\/#website"},"datePublished":"2014-10-28T12:21:35+00:00","breadcrumb":{"@id":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.clpu.es\/rss_externo\/new-clinical-trial-data-multiple-sclerosis-drug-candidate-also-shows-promise-for-ulcerative-colitis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.clpu.es\/en\/"},{"@type":"ListItem","position":2,"name":"RSS externos","item":"https:\/\/www.clpu.es\/rss_externo\/"},{"@type":"ListItem","position":3,"name":"New clinical trial data: Multiple sclerosis drug candidate also shows promise for ulcerative colitis"}]},{"@type":"WebSite","@id":"https:\/\/www.clpu.es\/#website","url":"https:\/\/www.clpu.es\/","name":"CLPU","description":"Centro de L\u00e1seres Pulsados","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.clpu.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/rss_externo\/11696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/rss_externo"}],"about":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/types\/rss_externo"}],"author":[{"embeddable":true,"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/users\/2"}],"wp:attachment":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/media?parent=11696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}